# Exploring Host-driven Immunopathological Factors Developing Severe Tuberculosis: Insights from Comparative Mouse Models

**Authors:** Hongmin Kim, Kee Woong Kwon, Hagyu Kim, WeonSeok Jung, Kyungmin Kim, Jung Joo Hong, Sung Jae Shin

PMC · DOI: 10.7150/ijbs.124878 · 2026-02-04

## TL;DR

This study identifies how immune factors like neutrophil levels and signaling molecules contribute to severe tuberculosis in mice, offering new insights into disease progression.

## Contribution

The study reveals novel mechanistic links between neutrophil-to-T cell ratios, granulocyte progenitor expansion, and type I IFN signaling in TB immunopathology.

## Key findings

- C3H/HeJ and A/J mice showed increased TB susceptibility linked to elevated neutrophil infiltration and G-CSF levels.
- Depletion of neutrophils or blocking type I IFN reduced disease severity and normalized immune cell ratios.
- Strain-specific protective effects were tied to restored neutrophil-to-T cell ratios and reduced GMP expansion.

## Abstract

Tuberculosis (TB) pathogenesis arises from complex interactions between host immune responses and the genetic diversity of Mycobacterium tuberculosis (Mtb). To elucidate host determinants of TB immunopathology, we conducted a comparative analysis of inbred mouse strains infected with the highly virulent Mtb K strain. Among the strains tested, C3H/HeJ and A/J mice exhibited markedly increased susceptibility, characterized by elevated pulmonary bacterial burdens and extensive necrotizing lung pathology. Interestingly, at 2 weeks post-infection (PI), both strains showed lower bacterial burdens, limited dissemination, and less pulmonary inflammation than C57BL/6 mice, but at 4 weeks PI, this trend reversed. The increased disease severity was closely associated with pronounced pulmonary neutrophilic infiltration, elevated systemic levels of granulocyte colony-stimulating factor (G-CSF), expansion of Lin⁻Sca-1⁻c-Kit⁺CD34⁺CD16/32⁺ granulocyte-monocyte progenitors (GMPs) in the bone marrow (BM), and a substantially increased pulmonary neutrophil-to-T cell (N/T) ratio, which positively correlated with disease progression. Depletion of neutrophils or blockade of type I IFN from 2 weeks PI significantly ameliorated disease severity, as evidenced by reduced bacterial burden, improved lung pathology, and normalization of the N/T ratio. Notably, IL-10 receptor blockade and aging specifically mitigated disease severity in A/J mice, whereas BCG vaccination conferred greater protection in C3H/HeJ mice. These strain-specific protective effects were consistently associated with restored N/T ratios, normalized GMP levels, and attenuated systemic G-CSF levels. Together, our findings identify the pulmonary N/T ratio and GMP expansion as central, mechanistically linked drivers of type I IFN signaling and neutrophil-mediated TB immunopathology.

## Linked entities

- **Proteins:** CSF3 (colony stimulating factor 3), IL10 (interleukin 10)
- **Diseases:** Tuberculosis (MONDO:0018076), TB (MONDO:0018076)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, Cxcr2 (C-X-C motif chemokine receptor 2) [NCBI Gene 12765] {aka CD128, CDw128, Cmkar2, Gpcr16, IL-8Rh, IL-8rb}, Cd28 (CD28 antigen) [NCBI Gene 12487], Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Cxcl5 (C-X-C motif chemokine ligand 5) [NCBI Gene 20311] {aka AMCF-II, Cxcl6, ENA-78, GCP-2, LIX, Scyb5}, Siglecf (sialic acid binding Ig-like lectin F) [NCBI Gene 233186] {aka Siglec5, mSiglec-F}, Nt5c2 (5'-nucleotidase, cytosolic II) [NCBI Gene 76952] {aka 2010002I23Rik, CnII, Gm9751, Gmp, Nt5b, Pnt5}, Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, Ifnb1 (interferon beta 1, fibroblast) [NCBI Gene 15977] {aka IFN-beta, IFNB, If1da1, Ifb}, Ighv1-9 (immunoglobulin heavy variable 1-9) [NCBI Gene 668478] {aka Gm16697, Igg2a}, LOC105243590 (Ig heavy chain Mem5-like) [NCBI Gene 105243590] {aka IgH, Igg1}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, Cd34 (CD34 antigen) [NCBI Gene 12490], Atxn1 (ataxin 1) [NCBI Gene 20238] {aka 2900016G23Rik, Atx1, Gm10786, Sca1}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Tlr9 (toll-like receptor 9) [NCBI Gene 81897], Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Sst1 (susceptibility to tuberculosis 1) [NCBI Gene 112256], Fas (Fas cell surface death receptor) [NCBI Gene 14102] {aka APO1, APT1, CD95, TNFR6, Tnfrsf6, lpr}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Fcgr1 (Fc receptor, IgG, high affinity I) [NCBI Gene 14129] {aka CD64, FcgammaRI, IGGHAFC}, Il10ra (interleukin 10 receptor, alpha) [NCBI Gene 16154] {aka CDw210, CDw210a, IL-10R1, IL-10RA, Il10r, mIL-10R}, Sp140 (Sp140 nuclear body protein) [NCBI Gene 434484], Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Il1r1 (interleukin 1 receptor, type I) [NCBI Gene 16177] {aka CD121a, CD121b, IL-1R-1, IL-1R-alpha, IL-1R1, IL-1RT-1}, Kit (Kit proto-oncogene receptor tyrosine kinase) [NCBI Gene 16590] {aka Bs, CD117, Fdc, Gsfsco1, Gsfsco5, Gsfsow3}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il5 (interleukin 5) [NCBI Gene 16191] {aka Il-5}, Ifnar1 (interferon (alpha and beta) receptor 1) [NCBI Gene 15975] {aka Ifar, Ifnar, Ifrc, Infar}, Ly6a (lymphocyte antigen 6 family member A) [NCBI Gene 110454] {aka Ly-6A.2, Ly-6A/E, Ly-6E.1, Sca-1, Sca1, TAP}, Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cd101 (CD101 antigen) [NCBI Gene 630146] {aka EWI-101, Gm1016, Gm734, Igsf2}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}
- **Diseases:** infectious (MESH:D003141), lung impairments (MESH:D009422), tissue (MESH:D017695), lipoid pneumonia (MESH:D011017), necrosis (MESH:D009336), TB meningitis (MESH:D014390), bacterial pneumonia (MESH:D018410), granulomas (MESH:D006099), ATB (MESH:D014376), lung inflammation (MESH:D011014), NET (MESH:C536657), Bacterial (MESH:D001424), latent TB (MESH:D055985), weight loss (MESH:D015431), drug toxicity (MESH:D064420), PI (MESH:D000094025), lung (MESH:D008171), T (MESH:D001260), tumor (MESH:D009369), pulmonary TB (MESH:D014397), -infection (MESH:D007239), neutrophilia (MESH:C563010), neutrophil (MESH:C564275), deaths (MESH:D003643), epithelial injury (MESH:D009375), inflamed (MESH:C531841), inflammation (MESH:D007249)
- **Chemicals:** ROS (MESH:D017382), formalin (MESH:D005557), DAPI (MESH:C007293), citrulline (MESH:D002956), biotin (MESH:D001710), PBS (MESH:D007854), TRIzol (MESH:C411644), lipid (MESH:D008055), citrate (MESH:D019343), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), agar (MESH:D000362), Triton X-100 (MESH:D017830), poly(I:C) (MESH:D011070), N (MESH:D009584), xylene (MESH:D014992), amphotericin B (MESH:D000666), Alexa Fluor  647 (MESH:C569686), CpG ODNs 1826 (MESH:C423449), T (MESH:D014316), H&amp;E (MESH:D006371), ACK (-), Paraffin (MESH:D010232)
- **Species:** Mycobacteriales (order) [taxon 85007], Influenza A virus (no rank) [taxon 11320], Homo sapiens (human, species) [taxon 9606], Mycobacterium tuberculosis variant bovis BCG (no rank) [taxon 33892], Mycobacterium tuberculosis (species) [taxon 1773], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Bacillus sp. CG (species) [taxon 1196795]
- **Mutations:** C with 50, W16030C
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), MOPC-21 — Mus musculus (Mouse), Mouse multiple myeloma, Cancer cell line (CVCL_T277), ATCC 27294 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965220/full.md

---
Source: https://tomesphere.com/paper/PMC12965220